California Pacific Medical Center Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, California Pacific Medical Center Research Institute sits in the top decile of US sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count).
California Pacific Medical Center Research Institute: 29 sponsored US clinical trials, 3 recruiting.
California Pacific Medical Center Research Institute sponsors 29 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 24 completed. 3 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Intensive Care Unit Days, with 1 trials.
Top-decile sponsor footprint
California Pacific Medical Center Research Institute ranks in the top decile of sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
24 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
29 total, page 1 of 1
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
NCT05988385
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
NCT05077280
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
NCT01750619
Trial of Parkinson's And Zoledronic Acid
NCT03924414
The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).
NCT02845401
CBT-I or Zolpidem/Trazodone for Insomnia
NCT04468776
Mindfulness and Migraine Research Study
NCT02824250
CPMC Early Undifferentiated Arthritis Registry
NCT02353221
Adherence Monitoring For Substance Abuse Clinical Trials
NCT01867476
Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps
NCT01712048
EUS-Guided Rendezvous or Direct Interventions Versus Advanced ERCP Techniques for Biliary Access and Therapy
NCT01678326
Feasibility of Endoscopic Ultrasound Based Biliary Stone Removal Without Fluoroscopy
NCT01678391
A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
NCT01354470
The PERFusion Use in Stroke Evaluation Study
NCT01387113
Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer
NCT01356030
Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma
NCT01743157
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
NCT01053403
Study of Naltrexone for Methamphetamine Addiction
NCT00984360
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects
NCT00829777
Role of Serotonin in Acute and Subacute MDMA Effects
NCT00838305
Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
NCT00823407
Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation
NCT00829634
A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence
NCT00538655
Proactive Ethics Intervention to Improve Intensive Care Unit (ICU) Care
NCT00996814
Clinical Trial of Sutent to Treat Metastatic Melanoma
NCT00631618
Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
NCT00713284
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
NCT00630682
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
NCT00259805
Distance Healing in Wound Healing
NCT00067717
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 4 | 3 |
What is open in the California Pacific Medical Center Research Institute pipeline
3 recruiting of 29 indexed (10% open); 24 completed (83%).
Phase mix: 3 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Intensive Care Unit Days (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
California Pacific Medical Center Research Institute: open-pipeline peers nationwide
Peers matched on 29 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
California Pacific Medical Center Research Institute sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 29 trials (± recruiting share)
- BeOne Medicines · 29 trials · 79% recruiting
- BioCryst Pharmaceuticals · 29 trials · 7% recruiting
- Center for International Blood and Marrow Transplant Research · 29 trials · 24% recruiting
- Craig Hospital · 29 trials · 21% recruiting
Sponsors near 10% open enrollment (± trial volume)
- National Institute of Environmental Health Sciences (NIEHS) · 10% recruiting · 145 trials
- University of Rhode Island · 10% recruiting · 29 trials
- SWOG Cancer Research Network · 10% recruiting · 270 trials
- University of Mississippi Medical Center · 10% recruiting · 96 trials
Related
What to do with this California Pacific Medical Center Research Institute page
29 registered trials is a research-attention snapshot, not an endorsement of California Pacific Medical Center Research Institute or any single study.
- 3 of California Pacific Medical Center Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Intensive Care Unit Days is the condition California Pacific Medical Center Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intensive Care Unit Days trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
California Pacific Medical Center Research Institute pipeline card: 29 registered trials from official public datasets.Report a data error.